OTCMKTS:CVALF Covalon Technologies (CVALF) Stock Price, News & Analysis $2.55 +0.16 (+6.69%) As of 01:05 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and Trends About Covalon Technologies Stock (OTCMKTS:CVALF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Covalon Technologies alerts:Sign Up Key Stats Today's Range$2.45▼$2.5850-Day Range$1.47▼$2.5552-Week Range$1.16▼$2.58Volume50,787 shsAverage Volume15,843 shsMarket Capitalization$70.43 millionP/E Ratio23.18Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials. The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components. Its hydrogel dressings are designed to maintain a moist healing environment, manage exudate, and provide sustained antimicrobial protection. Covalon’s coating technology is applied to catheters, implantable devices and wound-care products to inhibit bacterial adhesion and biofilm formation, addressing a critical need in hospital and outpatient surgical settings. Covalon has secured regulatory approvals in Canada and holds CE marking for distribution across Europe. The company is actively pursuing regulatory clearance in the United States and has established distribution partnerships in Asia and the Middle East. Its products are supplied to hospitals, surgical centers and wound-care clinics, where infection prevention and efficient healing are paramount to patient outcomes. Founded in the late 1980s, Covalon pivoted to focus on medical polymer applications in the early 2000s and has since built a pipeline of antimicrobial and anti-adhesion technologies. The company’s leadership team brings together expertise in polymer chemistry, medical device development and clinical research to advance its platform. Covalon continues to invest in research and development to expand its product offerings and geographic reach, supporting healthcare professionals in the global fight against device-associated infections and chronic wounds.AI Generated. May Contain Errors. Read More Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVALF Stock News HeadlinesCovalon Reports Fiscal 2026 Third Quarter ResultsAugust 27, 2026 | businesswire.comCovalon Technologies Ltd CVALFAugust 21, 2026 | morningstar.comMMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by robots but by America's oil and gas infrastructure. It's called the Patriot Income Plan, or P.I.P., and it pays 10% a year across 42 separate distribution dates. This year it's on track to pay out a record 53 billion dollars. Think of it as a personal stake in the world's largest energy producer, structured to deliver income on a regular schedule.September 8 at 1:00 AM | Freedom Financial (Ad)Covalon Technologies Ltd (CVALF) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ...May 21, 2026 | finance.yahoo.comCovalon Reports 2026 Second Quarter ResultsMay 21, 2026 | businesswire.comEvidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual MeetingMay 13, 2026 | businesswire.comCovalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound CareApril 15, 2026 | businesswire.comCovalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual MeetingApril 10, 2026 | businesswire.comSee More Headlines CVALF Stock Analysis - Frequently Asked Questions How have CVALF shares performed this year? Covalon Technologies' stock was trading at $1.25 on January 1st, 2026. Since then, CVALF stock has increased by 104.0% and is now trading at $2.55. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (OTCMKTS:CVALF) issued its quarterly earnings data on Thursday, August, 27th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.06. The business had revenue of $7.07 million for the quarter, compared to the consensus estimate of $6.65 million. Covalon Technologies had a net margin of 12.77% and a trailing twelve-month return on equity of 15.54%. How do I buy shares of Covalon Technologies? Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/27/2026Today9/08/2026Fiscal Year End9/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:CVALF CIKN/A Webwww.covalon.com Phone(905) 568-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$0.11 Trailing P/E Ratio23.18 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.47 million Net Margins12.77% Pretax Margin5.06% Return on Equity15.54% Return on Assets12.96% Debt Debt-to-Equity RatioN/A Current Ratio7.57 Quick Ratio5.85 Sales & Book Value Annual Sales$23.43 million Price / Sales3.01 Cash Flow$0.08 per share Price / Cash Flow30.44 Book Value$0.80 per share Price / Book3.19Miscellaneous Outstanding Shares27,620,000Free FloatN/AMarket Cap$70.43 million OptionableNot Optionable Beta0.64 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:CVALF) was last updated on 9/8/2026 by MarketBeat.com Staff. From Our PartnersThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredModerna’s 177% Surge Puts Cancer Biotech Back in FocusModerna shares surged 177% in a single trading session on August 19, adding about $45 billion in market value ...The Tomorrow Investor | SponsoredThey're not buying gold. They're buying this.Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...Behind the Markets | SponsoredSpaceX pays a 10X launch penaltySpaceX burns roughly $200,000 in fuel per Falcon 9 launch - about $20 million across 100 missions. One unde...Freedom Financial | Sponsored2:59 PM Friday. I make this trade.Tim Sykes says he books gains almost every weekend using one simple move. The trade is placed around 2:59 p...Tim Sykes | SponsoredMusk just exposed the crack in his empireSpaceX's IPO raised approximately $85.7 billion in gross proceeds. Days later, the company revealed its combin...The Oxford Club | SponsoredBlackRock and Vanguard already own THISInstitutions own roughly 88 percent of an overlooked American oil and natural gas company. BlackRock holds 32 ...Monument Traders Alliance | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
